increasing prevalence of cvd diseases is driving the High Pressure Contrast Media Injectors Market
Technavio analyzes that the High Pressure Contrast Media Injectors Market is expected to grow at a CAGR of 12.2% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 111.9 million.There are various factors that contribute to the growth of the market. The global High Pressure Contrast Media Injectors market is witnessing significant growth due to the increasing prevalence of cardiovascular diseases (CVD). These diseases necessitate the use of high-pressure injectors for the efficient administration of contrast media during diagnostic imaging procedures. The market is expected to expand at a robust pace in the forecast period, driven by the rising number of diagnostic procedures and technological advancements in medical imaging equipment.
In the healthcare industry, high pressure contrast media injectors play a pivotal role in diagnostic procedures conducted in hospitals. These advanced medical devices are primarily utilized in CT scans, MRI, angiography, cardiac MRI, and perfusion MRI. Hospitals, as the primary consumers, significantly influence the market growth due to the increasing number of institutions, especially multi-specialty hospitals. Tier-1 and Tier-2 hospitals, which include super specialty and multi-specialty divisions, are significant buyers. Government-sponsored, privately-owned, and public-private partnership hospitals have the necessary budgets to invest in high-end equipment such as high pressure contrast media injectors, including Softbag injectors, disposables, motor-driven syringes, microprocessor control systems, and Isovue (iopamidol injection) platforms.
Know which region is leading the market growth by requesting a sample report
High Pressure Contrast Media Injectors Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The High Pressure Contrast Media Injectors Market encompasses advanced injector technology used in the healthcare sector to maximize utility and minimize contrast supply. These injectors, including syringeless and power injectors, reduce contrast doses for multiple modalities such as CT angiography. Waste reduction is a key focus, with Joint Commission compliance and technologies like FlowSens ensuring safety. Disposables and multi-patient injector platforms are popular, with offerings like Isovue (iopamidol injection) and motor-driven syringes featuring microprocessor control and touch-screen consoles. Single-head injectors employ saline advance and jump techniques, while dual-head injectors address air embolisms and small bubbles. CT and computed tomography applications benefit from these high-pressure injector systems.
The High Pressure Contrast Media Injectors market is a significant segment within the expansive global healthcare equipment industry. This sector is characterized by innovative injector technology designed to maximize utility, minimize contrast supply usage, and support multiple modalities. Technavio, a leading market research firm, positions this market as part of the broader healthcare equipment landscape, encompassing manufacturers of capital equipment, instruments, implants, accessories, and consumables for various disease areas. The global healthcare equipment market size is determined by the combined revenue generated by these entities. The healthcare equipment sector encompasses various device segments, including advanced, differentiated, and clinically tested data-driven devices.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted